Page last updated: 2024-10-28

haloperidol and Cancer of Pancreas

haloperidol has been researched along with Cancer of Pancreas in 4 studies

Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.

Research Excerpts

ExcerptRelevanceReference
"Inhibition of DRD2 in pancreatic cancer cells reduced proliferation and migration, and slowed growth of xenograft tumors in mice."1.43Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice. ( Auld, D; Bauer, AS; Büchler, MW; Costello, E; Fassan, M; Giese, NA; Greenhalf, W; Hackert, T; Hall, A; Hoheisel, JD; Huang, S; Jandaghi, P; Lathrop, M; Monast, A; Najafabadi, HS; Neoptolemos, JP; Papadakis, AI; Park, M; Riazalhosseini, Y; Sangwan, V; Scarpa, A; Sipos, B; Strobel, O; von Knebel Doeberitz, M; Zogopoulos, G, 2016)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Silvestris, N1
Brunetti, AE1
Russano, M1
Nardulli, P1
Jandaghi, P1
Najafabadi, HS1
Bauer, AS1
Papadakis, AI1
Fassan, M1
Hall, A1
Monast, A1
von Knebel Doeberitz, M1
Neoptolemos, JP1
Costello, E1
Greenhalf, W1
Scarpa, A1
Sipos, B1
Auld, D1
Lathrop, M1
Park, M1
Büchler, MW1
Strobel, O1
Hackert, T1
Giese, NA1
Zogopoulos, G1
Sangwan, V1
Huang, S1
Riazalhosseini, Y1
Hoheisel, JD1
Kim, SH1
Lee, HY1
Yi, H1
Ahn, YM1
Kim, YS1
Yano, S1
Kashima, K1
Daa, T1
Urabe, S1
Tsuji, K1
Nakayama, I1
Yokoyama, S1

Trials

1 trial available for haloperidol and Cancer of Pancreas

ArticleYear
Optimal control of nausea and vomiting with a three-drug antiemetic regimen with aprepitant in metastatic pancreatic cancer patients treated with first-line modified FOLFIRINOX.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2013, Volume: 21, Issue:11

    Topics: Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Benztropine; Camptoth

2013

Other Studies

3 other studies available for haloperidol and Cancer of Pancreas

ArticleYear
Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice.
    Gastroenterology, 2016, Volume: 151, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Animals; Apoptosis; Carcinoma, Pancreatic Ductal; Case-Control Studi

2016
Haloperidol induces demethylation and expression of the dual specificity phosphatase 6 gene in MIA PaCa-2 human pancreatic cancer cells.
    Life sciences, 2012, Dec-17, Volume: 91, Issue:25-26

    Topics: Antipsychotic Agents; Azacitidine; Cell Line, Tumor; Cell Proliferation; CpG Islands; DNA Methylatio

2012
An antigen retrieval method using an alkaline solution allows immunoelectron microscopic identification of secretory granules in conventional epoxy-embedded tissue sections.
    The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 2003, Volume: 51, Issue:2

    Topics: Acrylic Resins; Adrenal Gland Neoplasms; Buffers; Chromogranin A; Chromogranins; Epoxy Resins; Heati

2003